@article{APS11116,
author = {Xin Jiang and Min Yu and Wei-kai Wang and Li-yuan Zhu and Xian Wang and Hong-chuan Jin and Li-feng Feng},
title = {The regulation and function of Nrf2 signaling in ferroptosis- activated cancer therapy},
journal = {Acta Pharmacologica Sinica},
volume = {45},
number = {11},
year = {2024},
keywords = {},
abstract = {Ferroptosis is an iron-dependent programmed cell death process that involves lipid oxidation via the Fenton reaction to produce lipid peroxides, causing disruption of the lipid bilayer, which is essential for cellular survival. Ferroptosis has been implicated in the occurrence and treatment response of various types of cancer, and targeting ferroptosis has emerged as a promising strategy for cancer therapy. However, cancer cells can escape cellular ferroptosis by activating or remodeling various signaling pathways, including oxidative stress pathways, thereby limiting the efficacy of ferroptosis-activating targeted therapy. The key anti-oxidative transcription factor, nuclear factor E2 related factor 2 (Nrf2 or NFE2L2), plays a dominant role in defense machinery by reprogramming the iron, intermediate, and glutathione peroxidase 4 (GPX4)-related network and the antioxidant system to attenuate ferroptosis. In this review, we summarize the recent advances in the regulation and function of Nrf2 signaling in ferroptosis-activated cancer therapy and explore the prospect of combining Nrf2 inhibitors and ferroptosis inducers as a promising cancer treatment strategy.},
issn = {1745-7254}, url = {http://www.chinaphar.com/article/view/11116}
}